Danaher Corp Files 8-K on Financials and Debt

TL;DR

DHR filed an 8-K detailing its financial condition and various senior notes due between 2026 and 2049.

AI Summary

Danaher Corporation (DHR) filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing details various senior notes due in the coming years, including those due in 2026, 2027, 2028, 2030, 2031, 2039, and 2049.

Why It Matters

This filing provides investors with an update on Danaher's financial health and its outstanding debt obligations, which are crucial for assessing the company's financial stability and future investment potential.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.

Key Players & Entities

• Danaher Corporation (company) — Filer
• DHR (company) — Ticker Symbol
• 2026 (date) — Senior Notes Due Date
• 2027 (date) — Senior Notes Due Date
• 2028 (date) — Senior Notes Due Date
• 2030 (date) — Senior Notes Due Date
• 2031 (date) — Senior Notes Due Date
• 2039 (date) — Senior Notes Due Date
• 2049 (date) — Senior Notes Due Date

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common stock, $0.01 par value DHR New York Stock Exchange

Filing Documents

• dhr-20250113.htm (8-K) — 42KB
• dhr-20250113xex991.htm (EX-99.1) — 18KB
• selecteddanaherpresentat.htm (EX-99.1PRE) — 12KB
• dhr-20250113_g1.jpg (GRAPHIC) — 8KB
• dhrlogoa.jpg (GRAPHIC) — 8KB
• selecteddanaherpresentat001.jpg (GRAPHIC) — 289KB
• selecteddanaherpresentat002.jpg (GRAPHIC) — 132KB
• selecteddanaherpresentat003.jpg (GRAPHIC) — 106KB
• selecteddanaherpresentat004.jpg (GRAPHIC) — 81KB
• selecteddanaherpresentat005.jpg (GRAPHIC) — 118KB
• selecteddanaherpresentat006.jpg (GRAPHIC) — 106KB
• selecteddanaherpresentat007.jpg (GRAPHIC) — 117KB
• selecteddanaherpresentat008.jpg (GRAPHIC) — 99KB
• selecteddanaherpresentat009.jpg (GRAPHIC) — 198KB
• 0000313616-25-000002.txt ( ) — 2037KB
• dhr-20250113.xsd (EX-101.SCH) — 4KB
• dhr-20250113_def.xml (EX-101.DEF) — 10KB
• dhr-20250113_lab.xml (EX-101.LAB) — 36KB
• dhr-20250113_pre.xml (EX-101.PRE) — 20KB
• dhr-20250113_htm.xml (XML) — 9KB

02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 13, 2025, in advance of a public webcast presentation at the J.P. Morgan Healthcare Conference on January 14, 2025 Danaher Corporation issued a press release regarding the Company's estimated financial performance for the fourth quarter of 2024 and furnished pursuant to Item 2.02 of Form 8-K such press release as well as the presentation slides attached hereto, each of which is incorporated by reference herein. The presentation slides attached hereto contain certain information regarding Danaher's estimated financial performance for 2024. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01 FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS (c) Exhibits: Exhibit No. Description 99.1 Press release — "Danaher CEO to Comment on Financial Performance" 99.1PRE Selected Danaher Presentation Slides for J.P. Morgan Healthcare Conference on January 14, 2025 104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DANAHER CORPORATION Date: January 13, 2025 By: /s/ Matthew R. McGrew Matthew R. McGrew Executive Vice President and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR